288 related articles for article (PubMed ID: 26821156)
1. Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.
Takagi Y; Hosomi Y; Nagamata M; Watanabe K; Takahashi S; Nakahara Y; Yomota M; Sunami K; Okuma Y; Shimokawa T; Okamura T
Cancer Chemother Pharmacol; 2016 Mar; 77(3):559-64. PubMed ID: 26821156
[TBL] [Abstract][Full Text] [Related]
2. Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial.
Singh N; Baldi M; Kaur J; Muthu V; Prasad KT; Behera D; Bal A; Gupta N; Kapoor R
Cancer; 2019 Jul; 125(13):2203-2212. PubMed ID: 30825389
[TBL] [Abstract][Full Text] [Related]
3. Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
Schlei Z; Tan W; Faber MG; Chen H; Meagher A; Dy GK
Clin Lung Cancer; 2018 Nov; 19(6):467-475. PubMed ID: 30369425
[TBL] [Abstract][Full Text] [Related]
4. Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation.
Stoffregen CC; Odin EA; Carlsson GU; Kurlberg GK; Björkqvist HG; Tångefjord MT; Gustavsson BG
Anticancer Drugs; 2016 Jun; 27(5):439-46. PubMed ID: 26825869
[TBL] [Abstract][Full Text] [Related]
5. Rationale and Design of PEMVITASTART-An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B
Baldi M; Behera D; Kaur J; Kapoor R; Singh N
Clin Lung Cancer; 2017 Jul; 18(4):432-435. PubMed ID: 28073680
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.
Takagi Y; Hosomi Y; Sunami K; Nakahara Y; Okuma Y; Yomota M; Shimokawa T; Nagamata M; Iguchi M; Okamoto H; Okamura T; Shibuya M
Oncologist; 2014 Nov; 19(11):1194-9. PubMed ID: 25260366
[TBL] [Abstract][Full Text] [Related]
7. A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.
Minchom A; Mak D; Gunapala R; Walder D; Kumar R; Yousaf N; Hodgkiss A; Bhosle J; Popat S; O'Brien MER
PLoS One; 2019; 14(11):e0225509. PubMed ID: 31765437
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
Socinski MA; Raju RN; Neubauer M; Smith DA; Richards DA; Savin M; Ruxer RL; Reynolds CH; Zhan F; Bromund JL; Chen R; Obasaju C
J Thorac Oncol; 2008 Nov; 3(11):1308-16. PubMed ID: 18978567
[TBL] [Abstract][Full Text] [Related]
9. Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer.
Chiappori A; Bepler G; Barlesi F; Soria JC; Reck M; Bearz A; Barata F; Scagliotti G; Park K; Wagle A; Liepa AM; Zhao YD; Chouaki N; Iscoe N; von Pawel J
J Thorac Oncol; 2010 Mar; 5(3):369-75. PubMed ID: 20090562
[TBL] [Abstract][Full Text] [Related]
10. [Safety of pemetrexed according to the duration of vitamin B12 and folic acid supplementation prior to the first dose of pemetrexed].
Tsuda Y; Kitamura A; Nishimura N; Yagi N; Takayama S; Okafuji K; Tomishima Y; Jinta T; Koyama K; Ohde S; Gotoh K; Chohnabayashi N
Gan To Kagaku Ryoho; 2015 Apr; 42(4):471-5. PubMed ID: 25963695
[TBL] [Abstract][Full Text] [Related]
11. The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.
Kim YS; Sun JM; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2013 Aug; 81(2):231-5. PubMed ID: 23683535
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of vitamin support in lung adenocarcinoma patients treated with pemetrexed second-line chemotherapy].
Zeng X; Zhou C; Ouyang M; Qin Y; Yang H; Peng Y; Liu S
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):868-72. PubMed ID: 26887521
[TBL] [Abstract][Full Text] [Related]
13. A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
Latz JE; Karlsson MO; Rusthoven JJ; Ghosh A; Johnson RD
Cancer Chemother Pharmacol; 2006 Apr; 57(4):412-26. PubMed ID: 16322990
[TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation.
Tanaka H; Horiike A; Sakatani T; Saito R; Yanagitani N; Kudo K; Ohyanagi F; Horai T; Nishio M
Anticancer Drugs; 2015 Jun; 26(5):573-8. PubMed ID: 25714250
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
Lal R; Hillerdal GN; Shah RN; Crosse B; Thompson J; Nicolson M; Vikström A; Potter VA; Visseren-Grul C; Lorenzo M; D'yachkova Y; Bourayou N; Summers YJ
Lung Cancer; 2015 Aug; 89(2):154-60. PubMed ID: 26101013
[TBL] [Abstract][Full Text] [Related]
16. Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.
Singh N; Aggarwal AN; Kaur J; Behera D
Am J Clin Oncol; 2017 Feb; 40(1):75-82. PubMed ID: 25089530
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer.
Ohe Y; Ichinose Y; Nakagawa K; Tamura T; Kubota K; Yamamoto N; Adachi S; Nambu Y; Fujimoto T; Nishiwaki Y; Saijo N; Fukuoka M
Clin Cancer Res; 2008 Jul; 14(13):4206-12. PubMed ID: 18594001
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.
Clarke SJ; Boyer MJ; Millward M; Underhill C; Moylan E; Yip D; White S; Childs A; Beale P; Latz J; Suri A; Iglesias JL
Lung Cancer; 2005 Sep; 49(3):401-12. PubMed ID: 15923057
[TBL] [Abstract][Full Text] [Related]
19. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
Pujol JL; Paul S; Chouaki N; Peterson P; Moore P; Berry DA; Salzberg M
J Thorac Oncol; 2007 May; 2(5):397-401. PubMed ID: 17473654
[TBL] [Abstract][Full Text] [Related]
20. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
Yajnik CS; Lubree HG; Thuse NV; Ramdas LV; Deshpande SS; Deshpande VU; Deshpande JA; Uradey BS; Ganpule AA; Naik SS; Joshi NP; Farrant H; Refsum H
Asia Pac J Clin Nutr; 2007; 16(1):103-9. PubMed ID: 17215186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
